6527
明達醫
-1.60 (-2.07%)75.8029成交張數13.00本益比1.86股價淨值比3.83%殖利率2026-09-11資料日期
每股盈餘
柱為單季 EPS,線為近四季合計;近十年
| 季度 | 單季 EPS | 年增 | 近四季 EPS | 歸屬母公司淨利(億) | 淨利率 | ROE(季) | ROE(近四季) |
|---|---|---|---|---|---|---|---|
| 2026Q2 | 1.68 | 13.5% | 5.87 | 0.42 | 19.4% | 4.19% | 14.95% |
| 2026Q1 | 1.33 | -8.9% | 5.67 | 0.34 | 18.0% | 3.35% | 15.09% |
| 2025Q4 | 1.49 | 26.3% | 5.80 | 0.38 | 14.1% | 3.73% | 14.94% |
| 2025Q3 | 1.37 | 3.8% | 5.49 | 0.35 | 17.3% | 3.56% | 14.67% |
| 2025Q2 | 1.48 | 15.6% | 5.44 | 0.38 | 14.7% | 4.02% | 15.09% |
| 2025Q1 | 1.46 | 17.7% | 5.24 | 0.37 | 16.4% | 3.98% | 14.69% |
| 2024Q4 | 1.18 | 63.9% | 5.02 | 0.30 | 13.4% | 3.24% | 14.16% |
| 2024Q3 | 1.32 | 41.9% | 4.56 | 0.34 | 14.4% | 3.77% | 13.25% |
| 2024Q2 | 1.28 | -8.2% | 4.17 | 0.32 | 15.3% | 3.66% | 12.75% |
| 2024Q1 | 1.24 | 14.2% | 4.28 | 0.31 | 15.7% | 3.59% | 12.74% |
| 2023Q4 | 0.72 | -40.9% | 4.13 | 0.19 | 9.8% | 2.19% | 12.67% |
| 2023Q3 | 0.93 | -34.9% | 4.63 | 0.23 | 10.6% | 2.88% | 14.47% |
| 2023Q2 | 1.39 | 30.7% | 5.13 | 0.34 | 16.7% | 4.36% | 17.03% |
| 2023Q1 | 1.09 | 23.9% | 4.80 | 0.27 | 13.0% | 3.42% | 15.55% |
| 2022Q4 | 1.22 | 29.3% | 4.59 | 0.31 | 13.2% | 3.99% | 15.39% |
| 2022Q3 | 1.43 | 108.3% | 4.31 | 0.36 | 17.1% | 4.83% | 14.87% |
| 2022Q2 | 1.07 | 53.4% | 3.57 | 0.27 | 12.3% | 3.64% | 12.46% |
| 2022Q1 | 0.88 | 15.0% | 3.20 | 0.22 | 16.0% | 3.02% | 11.17% |
| 2021Q4 | 0.94 | 47.8% | 3.09 | 0.24 | 12.2% | 3.33% | 11.08% |
| 2021Q3 | 0.69 | -22.6% | 2.78 | 0.17 | 9.5% | 2.43% | 10.32% |
| 2021Q2 | 0.70 | 192.0% | 2.98 | 0.17 | 10.3% | 2.49% | 11.00% |
| 2021Q1 | 0.76 | 63.2% | 2.52 | 0.19 | 10.8% | 2.79% | 9.06% |
| 2020Q4 | 0.64 | – | 2.23 | 0.16 | 9.4% | 2.43% | – |
| 2020Q3 | 0.89 | – | – | 0.22 | 14.6% | 3.41% | – |
| 2020Q2 | 0.24 | – | – | 0.06 | 9.5% | 0.87% | – |
| 2020Q1 | 0.47 | – | – | 0.12 | 10.5% | – | – |